CSI Market
Sign In | Register

Sonnet Biotherapeutics Holdings Inc (SONN) Annual Income Statement

Annual · GAAP · USD millions
Access SONN quarterly income statements →
Observing income statement movements over recent quarters helps explain how Sonnet Biotherapeutics Holdings Inc adapts pricing, costs, and operating efficiency.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
2025 		(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax1.00
Total Revenue1.00
Costs & Expenses
Gross Profit1.00
Selling, Administration, Marketing-8.49
Depreciation & Amortization0.56
Research and Development Expense-8.36
Other Operating Expense / -Income33.13
Total operating costs including COS16.84
Operating income / -loss-15.84
Net Interest (-)Expense / Income0.00
Foreign Currency Transaction Gain (Loss), before Tax-0.11
Other loss / -income0.06
Total costs & expenses16.79
Income & Taxes
Income / -loss before income taxes-15.79
Income taxes expenses / -benefit0.22
Income after income taxes-16.01
Income / -loss from continuing operations-16.01
Preferred dividends-0.10
Net income / -loss-16.01
Income / -loss to shareholder-16.11
EBIT-15.79
EBITD-15.78
EBITDA-15.23
Earnings Per Share
Basic EPS (excl. extra items)-3.95
Extraordinary items0.00
Basic Net EPS-3.95
Basic shares outstanding (Mill. of Units)4.08
Diluted Net EPS-3.95
Diluted average shares (Mill. of Units)4.08
4 historic quarters locked

Sign in to unlock the full Sonnet Biotherapeutics Holdings Inc income statement history.

Sign In Create Free Account

About Sonnet Biotherapeutics Holdings Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: December 16, 2025
  • Original filing: form10-k.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.